Sisram Medical (HKSE:01696) Debt-to-Equity : 0.10 (As of Dec. 2023)

View and export this data going back to 2017. Start your Free Trial

What is Sisram Medical Debt-to-Equity?

Sisram Medical's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was HK$71 Mil. Sisram Medical's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was HK$278 Mil. Sisram Medical's Total Stockholders Equity for the quarter that ended in Dec. 2023 was HK$3,532 Mil. Sisram Medical's debt to equity for the quarter that ended in Dec. 2023 was 0.10.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Sisram Medical's Debt-to-Equity or its related term are showing as below:

HKSE:01696' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.01 Med: 0.1 Max: 7.96
Current: 0.1

During the past 10 years, the highest Debt-to-Equity Ratio of Sisram Medical was 7.96. The lowest was 0.01. And the median was 0.10.

HKSE:01696's Debt-to-Equity is ranked better than
68.91% of 698 companies
in the Medical Devices & Instruments industry
Industry Median: 0.215 vs HKSE:01696: 0.10

Sisram Medical Debt-to-Equity Historical Data

The historical data trend for Sisram Medical's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sisram Medical Debt-to-Equity Chart

Sisram Medical Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Equity

Get a 7-Day Free Trial

0.04

0.11

0.10

Sisram Medical Semi-Annual Data
	Dec14	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Debt-to-Equity	Get a 7-Day Free Trial													0.10	0.09	0.10	0.10	0.10

Competitive Comparison of Sisram Medical's Debt-to-Equity

For the Medical Devices subindustry, Sisram Medical's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sisram Medical's Debt-to-Equity Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Sisram Medical's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Sisram Medical's Debt-to-Equity falls into.

Sisram Medical Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Sisram Medical's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(71.366	+	277.592)	/	3532.458
	=	0.10

Sisram Medical's Debt to Equity Ratio for the quarter that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(71.366	+	277.592)	/	3532.458
	=	0.10

Sisram Medical (HKSE:01696) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Sisram Medical Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Sisram Medical's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Sisram Medical (HKSE:01696) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sisram Medical Ltd (HKSE:01696) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

HaHarash Street 18, Ofek Building 15, Industrial Park, Caesarea, ISR, 3079895

Website

https://www.sisram-medical.com

Sisram Medical Ltd is an investment holding company specializing in medical technology for healthcare. The company is mainly involved in the design, development, manufacture, and sale of energy-based aesthetic medical and minimally invasive treatment systems, non-EBD devices and cosmeceuticals. The company's products include Soprano Titanium, Colibri technology, and others. Some of the company's brands are Alma, Soprano, Harmony, and ClearLift. It operates through the following geographical segments: Europe, North America, Asia Pacific, Latin America, and the Middle East and Africa.

Executives

Fosun Holdings Limited
Fosun International Holdings Ltd.
Fosun International Limited
Guo Guangchang
Ample Up Limited
Fosun Industrial Co., Limited
Shanghai Fosun High Technology (group) Co., Ltd.
Shanghai Fosun Pharmaceutical (group) Co., Ltd.
Chindex Medical Limited

Sisram Medical (HKSE:01696) Headlines

No Headlines